Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease

Marco Pagani(Karolinska University Hospital)

European Journal of Nuclear Medicine and Molecular Imaging

April 30, 2018

10.1007/s00259-018-4033-0

Cited by 31

Related Papers

Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes

|The Lancet Neurology|2014|250

Neurobiological Correlates of EMDR Monitoring – An EEG Study

|PLoS ONE|2012|136